FATE THERAPEUTICS INC (FATE)

2.43 -4.33% (-0.11)

Over 5Y: -96.7%

2026-08-28
25 50 75
2021 2022 2023 2024 2025 2026

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 14.2M Q3 '21 — Operating Cash Flow: -33.4M Q3 '21 — Free Cash Flow: -48.1M Q3 '21 — Net Income: -43.3M Q4 '21 — Revenue: 17.1M Q4 '21 — Operating Cash Flow: -70.3M Q4 '21 — Free Cash Flow: -88.7M Q4 '21 — Net Income: -68.6M Q1 '22 — Revenue: 18.4M Q1 '22 — Operating Cash Flow: -64.6M Q1 '22 — Free Cash Flow: -74.7M Q1 '22 — Net Income: -65.7M Q2 '22 — Revenue: 18.5M Q2 '22 — Operating Cash Flow: -53.2M Q2 '22 — Free Cash Flow: -63.3M Q2 '22 — Net Income: -76.1M Q3 '22 — Revenue: 15M Q3 '22 — Operating Cash Flow: -55M Q3 '22 — Free Cash Flow: -63.7M Q3 '22 — Net Income: -83.6M Q4 '22 — Revenue: 44.4M Q4 '22 — Operating Cash Flow: -75.4M Q4 '22 — Free Cash Flow: -82.1M Q4 '22 — Net Income: -56.4M Q1 '23 — Revenue: 59M Q1 '23 — Operating Cash Flow: -28.9M Q1 '23 — Free Cash Flow: -32.1M Q1 '23 — Net Income: -18.9M Q2 '23 — Revenue: 933K Q2 '23 — Operating Cash Flow: -28.5M Q2 '23 — Free Cash Flow: -30.7M Q2 '23 — Net Income: -52.8M Q3 '23 — Revenue: 1.9M Q3 '23 — Operating Cash Flow: -38.3M Q3 '23 — Free Cash Flow: -38.8M Q3 '23 — Net Income: -45.2M Q4 '23 — Revenue: 1.7M Q4 '23 — Operating Cash Flow: -36.6M Q4 '23 — Free Cash Flow: -36.8M Q4 '23 — Net Income: -44.1M Q1 '24 — Revenue: 1.9M Q1 '24 — Operating Cash Flow: -33.4M Q1 '24 — Free Cash Flow: -33.4M Q1 '24 — Net Income: -48M Q2 '24 — Revenue: 6.8M Q2 '24 — Operating Cash Flow: -32.3M Q2 '24 — Free Cash Flow: -32.4M Q2 '24 — Net Income: -38.4M Q3 '24 — Revenue: 3.1M Q3 '24 — Operating Cash Flow: -29.4M Q3 '24 — Free Cash Flow: -29.9M Q3 '24 — Net Income: -47.7M Q4 '24 — Revenue: 1.9M Q4 '24 — Operating Cash Flow: -27.8M Q4 '24 — Free Cash Flow: -27.9M Q4 '24 — Net Income: -52.2M Q1 '25 — Revenue: 1.6M Q1 '25 — Operating Cash Flow: -33.8M Q1 '25 — Free Cash Flow: -35M Q1 '25 — Net Income: -37.6M Q2 '25 — Revenue: 1.9M Q2 '25 — Operating Cash Flow: -24.6M Q2 '25 — Free Cash Flow: -25.9M Q2 '25 — Net Income: -34.1M Q3 '25 — Revenue: 1.7M Q3 '25 — Operating Cash Flow: -24.4M Q3 '25 — Free Cash Flow: -26.6M Q3 '25 — Net Income: -32.2M Q4 '25 — Revenue: 1.4M Q4 '25 — Operating Cash Flow: -23.3M Q4 '25 — Free Cash Flow: -24.5M Q4 '25 — Net Income: -32.4M Q1 '26 — Revenue: 1.3M Q1 '26 — Operating Cash Flow: -30.8M Q1 '26 — Free Cash Flow: -31.1M Q1 '26 — Net Income: -31.2M Q2 '26 — Revenue: 2.1M Q2 '26 — Operating Cash Flow: -23.4M Q2 '26 — Free Cash Flow: -23.5M Q2 '26 — Net Income: -30.2M -60M -30M 0 30M 60M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.7
SBC / sales 274.8%
Oper. margin -2058.1%
Accruals -9.3%
Asset turnover 0.025×
EBITDA margin -1873.4%
FCF margin -1627.2%
OCF margin -1570.0%
ROA -48.4%
ROCE -58.7%
ROE -82.1%
Gross margin —
OCF / EBIT —
OE margin —
Profit margin —
ROIC —

3 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

1.0
RPO / sales —
RPO growth —
Segment HHI —

2 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

6.9
ND/EBITDA —
Cash runway 1.5 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 4.8×
F-score 1.3 pts
Cash / Debt —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

2.6
Sales CAGR 4Y -41.3%
Sales/sh Y/Y -26.7%
Sales Q/Q +9.2%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.